Log In
Get Started Free

cognitive cybersecurity intelligence

News and Analysis

Search

FDA Pilot Program Creates New Path for Faster Regulatory Review of Generic Drugs

FDA Pilot Program Creates New Path for Faster Regulatory Review of Generic Drugs

The FDA will provide faster regulatory review of generic drugs that are tested in and manufactured in the U.S. using domestically sourced active pharmaceutical ingredients. This FDA pilot program is part of a broader Trump administration strategy to reshore pharmaceutical production.
The post FDA Pilot Program Creates New Path for Faster Regulatory Review of Generic Drugs appeared first on MedCity News.

Source: medcitynews.com –
 Read more
Linkedin Youtube Facebook Instagram

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

Keeping Your Cloud Environment Safe

Keeping Your Cloud Environment Safe

Why Is Non-Human Identity Management Crucial for Cloud Safety? How can organizations effectively manage Non-Human Identities (NHIs) to maintain cloud safety? For industries that heavily

Keeping Your Cloud Environment Safe

Feeling Reassured by Your Secrets Security?

What Ensures Your Data Remains Protected at Every Stage? Non-Human Identities (NHIs) and Secrets Security Management form the backbone of fortified cybersecurity strategies, especially for